View all cases
- Case details
- Status—ActionProcedural applicationCategoryCase management orders
- Parties
- Respondents
- Dexcom Inc.Operating co.
- Dexcom International LimitedOperating co.
- Dexcom France SASOperating co.
Representatives- Thierry Lautier
- Division
- Paris LD
- Judges
- Technology
- InstrumentsMedical technology
- Mechanical engineeringHandling
- Language
- —
- First decided
- Jul 31, 2024
- EPO Opposition
- Dexcom, Inc.Withdrawn2024-04-12
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris LD | Locked |
| Judge Camille Lignières | Locked |
At the UPC: Abbott Group (67 cases)·Dexcom Group (39 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
CC 20188/2024·CC 13509/2024·UPC CFI 425/2023·UPC CFI 424/2023·UPC APP 44663/2024 and 4 more
3 other defendants litigating the same or a related patent
Decisions
- 2024-07-31Order Communicate InformationPublic
Summary: Paris Local Division order (judge-rapporteur Lignières) on Abbott Diabetes Care Inc.'s application (R. 191 RoP) to compel Dexcom entities to disclose the full distribution chain for the Dexcom G6 and G7 systems across Contracting Member States in infringement proceedings concerning EP 3 988 471. The order addresses timing and scope of the communication of information request, likely deferring or partially granting the request pending the interim conference, with Dexcom's alternative proposals for limitation and confidentiality considered.
Show the legal issues (3)
- Order to communicate information (Art. 67 UPCA, R. 191 RoP)
- Distribution chain disclosure for infringing products
- Continuous glucose monitoring device patents
Documents
- AD59A021EDBA0488FF5EB27AA488AED8_en.pdf2024-07-31EN